Pancreatic Cancer Drug Receives FDA Approval

Pancreatic Cancer Drug Receives FDA Approval The drug, daraxonrasib, was approved Wednesday and will be sold under the name Rasonque. In clinical trials, patients who were given the drug showed nearly double the average survival time compared with those treated with chemotherapy. https://kffhealthnews.org/morning-breakout/cancer-research-082726/